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When a cell is exposed to a sufficiently intense electric field (for a sufficient duration),
local defects in the cell membrane appear and become permeable to molecules that
otherwise cannot pass through it. This phenomenon is commonly known as electro-
poration but additional terms electropermeabilization and PEF (i.e. pulsed electric
field) treatment are commonly used as well (the latter mainly in food processing area).
In reversible electroporation, cell membrane permeabilization to molecules otherwise
deprived of transmembrane transport mechanisms is a transient phenomenon as after
some time membrane reseals and reestablishes its homeostatic semipermeable proper-
ties, allowing ions and other small molecules to passively cross. The cell can thus sur-
vive, though if the molecular transport disruptions to homeostasis is too great, the cell
will die and the process is termed irreversible electroporation. During this period of
increased membrane permeability, if the cell is surrounded by chemotherapeutics like
bleomycin and cisplatin they are able to enter the cell and access their intracellular tar-
gets. In this way, the increased transport of chemotherapeutics due to electroporation
increases the cytotoxic effects of certain drugs through potentiated mass transport per-
mitted by the state of increased membrane permeabilization. This process is commonly
referred to as electrochemotherapy and involves the combination of reversible electro-
poration and chemotherapy, allowing the latter to be successfully used as local tumor
treatment [1].
If the number of pulses is too great, their duration too long, or the amplitude of the
field to which the cell is exposed too intense, the cell dies due to irreversible electro-
poration presumably due to a loss of homeostasis. Irreversible electroporation was
introduced as an ablation method for normal and tumor tissue and quickly gained
much attention due to its non-thermal nature, enabling operators to spare critical
structures of the tissue matrix, such as vessels, while successfully eradicating tumor
cells. The term “non-thermal” refers to the mechanism of IRE, since cell death is due
to membrane electroporation and not a temperature increase of the tissue; although
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local temperature increases can occur around the electrodes especially if many pulses
are administered.
In this editorial, we highlight recent efforts to address some of the current challenges
associated with treating deep-seated tumors using electroporation-based therapies, how
several of the papers in this special issue address those challenges, and point readers to
several excellent review articles in the field for further background information [2-6].
This special issue is a result of a special session, which was organized by COST
TD1104 Action EP4Bio2Med (www.electroporation.net) at the MBEC2014 6th
European Conference of the International Federation for Medical and Biological Engi-
neering held in Dubrovnik, Croatia from September 7-11, 2014. It hosted a number of
distinguished speakers from around the world. The presentations were grouped into
three topics: clinical experience using electroporation based treatment of deep-seated
tumors, modeling and treatment planning for deep-seated tumors using electropora-
tion, and prognostic imaging in deep-seated tumors using electroporation.
Current challenges that have been identified during the special session when discuss-
ing either IRE or ECT of deep-seated tumors are: tissue conductivity determination
(necrotic regions, vasculature, micro-heterogeneities); conductivity changes due to elec-
troporation (amount and dynamics); threshold determination for electroporation
(reversible, irreversible) also as a function of pulse parameters (duration and number
of pulses); and the accuracy needed for treatment planning, positioning of electrodes,
which consequently dictates also accuracy and robustness of a treatment plan. Many of
these challenges have been further addressed in papers presented in this special issue
and although they do not offer immediate and ultimate responses to all of the chal-
lenges identified, they do show possible directions on how to approach many of them.
However, it is becoming clear that we will only be able to make this technology plat-
form available for widespread use by clinicians and provide the best outcome and ben-
efit for the patient through a holistic analysis of: imaging, treatment planning, and
clinical feedback.
From the point of view of the clinician, the challenge is that currently it takes too
long when compared to other minimally-invasive procedures such as microwave or
RFA due to the requirement of multiple needles for IRE whereas in RFA and micro-
wave, only one probe is inserted.
Electroporation based therapies currently require accurate placement of two of more
electrodes within the region of interest. At the present time IRE procedures tend to
extend for significantly longer time compared to other ablation technologies. Despite
the use of ultrasound (US) during the electrode placement process, it is challenging
and time-consuming; this is mainly due to the inherent nature of tumors treated with
IRE which are surrounded by critical structures. More extensive use and availability of
treatment planning will aide physicians with the electrode placement process given
that it illustrates, on a physics-based model, what the most optimal and feasible elec-
trode placement procedure may be.
The first paper by Liberti and colleagues describes modeling the positioning of single
needle electrodes for the treatment of breast cancer in a clinical case [7]. The paper
elegantly correlates numerical simulations with an actual clinical trial outcome–a topic
that remains presently underdeveloped in the literature–considering the great variabil-
ity present between cases and requisite development of a good cohort of trials to
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improve treatment planning for tumor tissue in clinical settings. It uses the resistance
data and histology outcomes from a breast tumor that underwent resection after per-
forming ECT in order to determine the theoretical oncologic outcome that would have
been encountered from the ECT. Their study analyzed the feasibility of using ECT to
treat patients with histologically proven unifocal ductal breast cancer. Due to the
tumor being located in a relatively low-conductivity fat tissue, their numerical model
reveals reduced electric field intensity induced inside the tumor with certain electrode
placement geometries. Their study agreed with animal results by Neal and others using
experiments in the mammary fat pad of mice and single insertion device that the field
distribution is heavily dependent on the surrounding environment [8,9]. The results
presented by Liberti et al. show that the effectiveness of the treatment can be enhanced
through the careful placement of the electrodes and that treatment models could be
used to identify better electrode configurations in planning the experimental protocols.
In treating deep seated tumors either during open surgery or percutaneously in liver
or other organs due to high voltage (up to 3000 V) and consequently high currents
(up to 50 A) delivered pulses could potentially interfere with cardiac activity [10].
Synchronization of delivery of electroporation pulses with ECG proved to reduce risk
of interference. Mali et al. only found clinically irrelevant changes in heart rate variabil-
ity (HRV) parameters after ECT procedure: a decrease in median values of the mean
NN interval, a decrease in the low-frequency and in the normalized low-frequency
component, and an increase in the normalized high-frequency component [11].
In addition to simplifying procedures by using a single insertion device, as described
in the previous paper, treatment planning can be used to mitigate some of the chal-
lenges with delivering effective ECT, IRE, and EGT therapies. Several studies have
been conducted to create more accurate treatment planning models [12-15] and pre-
clinical models have demonstrated their effectiveness [16,17].
The pioneering work by Groselj, G Sersa and colleagues demonstrated the power of
coupling treatment planning with a navigation system for the treatment of tumors
using electroporation-based therapies [18]. By integrating a treatment plan with a navi-
gation system, the navigation system was able to help the surgeon to identify the
tumors and accurately position five long needle electrodes for treatment of a patient
with head and neck tumors.
Although treatment planning is a powerful tool to aid clinicians in optimizing ther-
apy, there are tremendous challenges with predicting the treatment outcome. For a
given set of pulse parameters and tissue type, treatment outcome is determined by the
electric field distribution [19]. However, the impedance distribution is difficult to pre-
dict a priori due to local heterogeneities present within the tumor tissue (e.g., necrotic
core), tissue-to-tissue variability [20], patient-to-patient variability, and impedance
changes of the local tissue due to electroporation itself [21,22]. Electroporation-induced
dynamic tissue conductivity plays a significant role in redistribution of electrical con-
ductivity and thus electric field and ablation zone [23,24]. When cells become electro-
porated, their capacity to behave as dielectrics is dramatically reduced, thus facilitating
improved electric current flow through cellular regions relative to non-electroporated
tissues [25].
Numerical methods are most commonly used for pre-treatment planning of electro-
poration-based therapies because the complex geometries of the tumor and surrounding
Miklavcic and Davalos BioMedical Engineering OnLine 2015, 14(Suppl 3):I1
http://www.biomedical-engineering-online.com/content/14/S3/I1
Page 3 of 7
structures disallow the development of analytical estimation techniques. In order to
accurately model the electric field distribution, the impedance changes due to electro-
poration and tissue heterogeneities need to be characterized prior to treatment. Accord-
ingly, studies employing numerical models for pre-treatment planning have accounted
for the dynamically changing electrical properties of tissue [26-31], as well as the hetero-
geneous impedance in multiple geometries in the local tumor environment [20].
However, the presence of local heterogeneities in tumors (such as necrotic core), tissue-
to-tissue variability and patient-to-patient variability further complicates the prediction
of the impedance distributions.
Relevant inherent tissue heterogeneities include highly localized effects such as those
due to the presence of diverse interstitial constituents including macro- and microvas-
culature, connective tissue, general cellularity, cellular morphology, and discrete func-
tional organ units such as proximal convoluted tubules or glomerular capsules.
Furthermore, certain tissues may contain stochastic or organized aspects that will have
varying extent of an effect on electric field distributions, including presence of ran-
domly distributed calcifications, as well as structural tissue orientations that exhibit
anisotropic effects to electric field distribution. While this will occur for several tissue
varieties, the strongest effect is clearly exhibited in muscle tissue where the high con-
ductivity along muscle fibers compared to perpendicular to muscle fibers imparts a
strong effect on electric field distribution and ablation shape [32]. Furthermore, it is
too difficult to consider all of the subcellular to cellular-level variability within a tar-
geted environment, and thus effective bulk tissue conductivity is used as a metric to
approximate the overall conductivity for a particular tissue type. The electrical conduc-
tivity for different tissue types may more readily be identified and incorporated sepa-
rately on predictive numerical models.
More recently, theoretical studies on high-frequency bipolar pulses (≈ 1 us) have
shown that the use of bursts of such pulses helps achieve macroscopically homoge-
neous distributions on heterogeneous geometries [33,34].
The paper by Bhonsle et al. extends the advantages of high-frequency pulses and
shows that they mitigate the dynamic impedance changes during electroporation ther-
apy while achieving similar sized lesions as conventional unipolar pulses through the
use of higher voltage pulses [35]. This paves way for modeling the electric field distri-
bution in tissue using the analytical solution of the Laplace’s equation that is valid for
a homogeneous medium of constant conductivity. High-frequency pulses could have
implications of decreased tissue-to-tissue variability during electroporation therapy,
with one mathematical general solution fitting all tissues.
Although treatment planning is powerful, the tools are not available for all clinicians
using electroporation-based therapies. The paper by Marcan and colleagues demon-
strates how a web-based tool could allow users to build a 3D model of the target tissue
from uploaded medical images and then simulate the electric field distribution for
treatment planning [36]. This could be an invaluable tool for clinicians to carry out
patient-specific treatment planning for electroporation-based treatments without
advanced technical knowledge of the field.
Considering the challenges with predicting the impedance distribution beforehand
for treatment planning, researchers are using imaging techniques to assess the impe-
dance distribution within the tissue. Researchers have used medical images (e.g. MRI)
Miklavcic and Davalos BioMedical Engineering OnLine 2015, 14(Suppl 3):I1
http://www.biomedical-engineering-online.com/content/14/S3/I1
Page 4 of 7
in the past to determine precise anatomical geometries of the tumor and surrounding
tissues and assign tissues with appropriate electrical properties [26,16,17,37]. However,
as mentioned before, knowledge of these properties prior to treatment is difficult to
ascertain.
The electric field distribution generated in a given tissue determines the outcome of
electroporation based therapies. Previously, in situ imaging methods, such as electrical
impedance tomography (EIT) [31] and magnetic resonance electrical impedance tomo-
graphy (MREIT) [38], have been proposed to monitor the electric field distribution in
real-time. Despite promising results, these methods are not yet well adopted for elec-
troporation treatments due to the complexities involved in their implementation [39].
The paper by Igor Sersa and colleagues demonstrates a novel approach of using cur-
rent density imaging (CDI) to monitor electroporation-based therapy [40]. Their
approach overcomes several of the technical challenges associated with using other
imaging modalities. They successfully imaged the current distribution during delivery
of microsecond high-voltage electroporation pulses. Their approach has the potential
to enable monitoring of tumor coverage by the applied electric field during irreversible
electroporation therapy and potentially other electroporation based therapies, such as
electrochemotherapy and gene therapy by electroporation.
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